Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Anaesthesiology Clinical Pharmacology
- Vol. 33 (3) , 317-323
Abstract
Background and Aims: The aim is to evaluate the association between the use of intraoperative dexmedetomidine with an increase in recurrence-free survival (RFS) and overall survival (OS) after nonsmall cell lung cancer (NSCLC) surgery. Material and Methods: This was a propensity score-matched (PSM) retrospective study. Single academic center. The study comprised patients with Stage I through IIIa NSCLC. Patients were excluded if they were younger than 18 years. Primary outcomes of the study were RFS and OS. RFS and OS were evaluated using univariate and multivariate Cox proportional hazards models after PSM (n = 251/group) to assess the association between intraoperative dexmedetomidine use and the primary outcomes. The value of P < 0.05 was considered statistically significant. Results: After PSM and adjusting for significant covariates, the multivariate analysis demonstrated no association between the use of dexmedetomidine and RFS (hazard ratio [HR] [95% confidence interval (CI)]: HR = 1.18, 95% CI: 0.91–1.53; P = 0.199). The multivariate analysis also demonstrated an association between the administration of dexmedetomidine and reduced OS (HR = 1.28, 95% CI: 1.03–1.59; P = 0.024). Conclusions: This study demonstrated that the intraoperative use of dexmedetomidine to NSCLC patients was not associated with a significant impact on RFS and but worsening OS. A randomized controlled study should be conducted to confirm the results of this study.Keywords
This publication has 29 references indexed in Scilit:
- Lack of Association Between Dexamethasone and Long-Term Survival After Non–Small Cell Lung Cancer SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2016
- Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian CancerAnnals of Surgical Oncology, 2014
- A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non‐small cell lung cancer resectionCancer Medicine, 2014
- Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancerJournal of Clinical Anesthesia, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective studyBMC Anesthesiology, 2013
- Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer SurgeryAnnals of Surgical Oncology, 2013
- Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 InhibitorThe Journal of Immunology, 2010
- Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger PatientsJournal of Thoracic Oncology, 2009
- The Role of the α2-Adrenoceptor Agonist Dexmedetomidine in Postsurgical Sedation in the Intensive Care UnitJournal of Intensive Care Medicine, 2003